Clinical efficiency NEVA focuses on timely vascular access to reduce treatment delays and expedite discharges, presenting opportunities to partner with hospitals and long-term care facilities aiming to improve patient flow and reduce length of stay.

Diversified access With a portfolio including midline, peripheral IVs, and internal jugular access for renal patients, NEVA can upsell a broader access solution to facilities seeking to consolidate vendors and standardize device choices.

Quality and outcomes Emphasis on the lowest complication rates and right device at the right time positions NEVA as a quality-focused partner for hospitals prioritizing patient safety metrics and reduced readmissions.

Market fit Revenue size indicates a small to mid-market footprint ideal for regional hospital systems, long-term care providers, and specialty clinics seeking specialized vascular access expertise.

Growth signals Recent activity and conference exposure, such as presenting clinical experience data, suggest opportunities to leverage thought leadership and educational collaborations to drive trialing of NEVA devices in new accounts.